Va14 TCR expressing invariant NK T (iNKT) cells recognize a-galactosylceramide (aGC)/CD1d complex and produce large amounts of various cytokines before the onset of the adaptive immunity. After stimulation with a high dose (2-5 mg) of aGC in vivo, iNKT cells in the spleen and liver become anergic in terms of the proliferation and cytokine production to subsequent stimulation. In this study, we monitor how iNKT anergy is induced. Anergized iNKT cells dramatically reduced the expression of IL-2Ra, and exogenous IL-2 restored the ability to proliferate and produce IL-4 but not to produce IFN-g. Anergized iNKT cells expressed high levels of programmed death-1 (PD-1). However, iNKT cells in PD-1-deficient mice became anergic as a result of aGC injection, as do normal mice. Furthermore, anti-PD-1 blocking mAb was unable to restore their responsiveness. When iNKT cells were stimulated with immobilized anti-CD3 in the presence or absence of anti-CD28, they produced cytokines in a dose-dependent manner. Unlike in naive CD4 T cells, the strong TCR-mediated signaling with co-stimulation renders them anergic to any subsequent stimulation with aGC and spleen dendritic cells (DCs). Moreover, iNKT cells also became anergic after stimulation with phorbol-12-myristate-13-acetate 1 ionophore. Finally, the injection of aGC-pulsed DCs was more potent in inducing anergy than B cells. These results indicate that strong TCR-mediated activation with co-stimulation provides signals that induce the anergic state in iNKT cells.
Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation Introduction NKT cells that express both TCRab and NK1.1, an NK cell marker in mouse (1), recognize glycolipid, which is presented by MHC class I-like molecules, CD1d. Although there are several candidates of natural ligand for NKT cells (2), Va14-expressing invariant NKT (iNKT) cells rapidly produce large amounts of cytokines, such as IFN-c and IL-4, after recognizing a synthetic glycolipid antigen derived from marine sponges called a-galactosylceramide (aGC) (3). CD1d is expressed on a broad range of cells. Even though marginal zone B (MZB) cells express the highest level of CD1d (4), dendritic cells (DCs) are much more potent antigen-presenting cells (APCs) for iNKT cells than MZB cells both in vitro and in vivo (5) . When iNKT cells recognize aGC/CD1d complex, they up-regulate CD40 ligand expression. Through the CD40/CD40 ligand interactions, activated DCs produce IL-12 and up-regulate the expression of co-stimulatory molecules such as CD80 and CD86 (6) (7) (8) (9) . Thus, mutual interactions between iNKT cells and DCs reciprocally activate each other and bring about the cytokine storm, leading to the effective immune responses (7, 8) .
It has also been reported that aGC treatment accelerates T h 2-type cytokine production (10) and prevents the development of type 1 diabetes in non-obese diabetic mice (11, 12) . However, a single injection of aGC at 100 lg kg À1 rendered iNKT cells unresponsive (anergic) to re-stimulation in vitro, although they activated iNKT cells to produce cytokines (13) (14) (15) (16) (17) . In conventional T cells, it has been considered that TCR signaling without the co-stimulatory signal induces anergy without producing IL-2 or other cytokines (18) (19) (20) . Thus, the mechanisms by which anergy is caused appear to be different for T cells and iNKT cells. However, it is not yet clear how the co-stimulatory signal is involved in the induction of iNKT cells. Recently, immunosuppressive programmed death-1 (PD-1) molecule has been shown to play a role in the induction and/or maintenance of the anergic state in iNKT cells (15, 17) .
Here we show that, in contrast to naive T cells, iNKT cells become anergic only when they are given strong activation signals through TCR along with co-stimulation, such as with anti-CD3 + anti-CD28 and phorbol-12-myristate-13-acetate (PMA) + ionomycin. This was also confirmed by experiments in which iNKT cell anergy was induced when DCs were pulsed with a high dose of aGC and a large number of these aGC-pulsed DCs were then injected. Consistent with these finding, aGC-loaded DCs were much more potent in rendering iNKT cells anergic than B cells. Therefore, it is conceivable that DCs are primary APCs and not only activate iNKT cells but also drive them into the anergic state.
Methods

Mice
C57BL/6 mice were purchased from SLC Japan (Hamamatsu, Shizuoka, Japan). OT-II mice from Dr F. Carbone (University of Melbourne, Parkville, Victoria, Australia) and PD-1 knockout (KO) mice from Dr T. Honjo (Kyoto university, Kyoto, Japan) were maintained under specific pathogen-free conditions in our animal facility and used at 8-12 weeks of age. Animal care and use were as per the institutional guidelines of Kyoto University.
Antibodies and reagents
Purified anti-mouse IFN-c and IL-2, FITC-conjugated antimouse CD45R, PE-conjugated anti-mouse IgG 1 , biotinconjugated anti-mouse CD28 and TCRb, biotin-conjugated isotype control IgG, streptavidin-conjugated PE-Cy5, CD1d-dimer XI, anti-CD4 IMag-MSC and recombinant mouse IL-4, IL-12p70 and IFN-c were purchased from BD Biosciences (San Diego, CA, USA). Purified IL-4, anti-CD3e and CD28, FITC-conjugated anti-mouse CD19, biotin-conjugated Abs for mouse IL-4, IFN-c, IL-2, CD25, CD122, PD-1 and B-and T-lymphocyte attenuator (BTLA) were from e-Bioscience (San Diego, CA, USA). Recombinant mouse IL-2 and IL-15 and biotinylated anti-mouse IL-15 receptor b (IL-15Rb) were obtained from R&D Systems (Minneapolis, MN, USA). Magnetic cell sorter (MACS) microbeads conjugated with CD11c, CD19 and PE were from Miltenyi Biotec GmbH (Bergisch Gladbach, Germany), and Dynabeads conjugated with sheep anti-rat IgG were from Invitrogen Life Technologies (Carlsbad, CA, USA). mAbs for CD16/32 (2.4G2), B220 (RA3-6B2.1), MHC class II (M5/114.15.2), CD11b (M1/70), CD8a (53-6.72), Gr-1 (RB6-8C5) and CD62L (Mel-14.d54) were culture supernatants of hybridoma (American Type Culture Collection, Manassas, VA, USA). aGC was provided by Kirin Brewery Co., Ltd (Gunma, Japan). Purified anti-PD-1 mAb (RMP1-14) was a kind gift from Dr H. Yagita (Juntendo University School of Medicine, Tokyo, Japan).
iNKT cell anergy induction, cell preparation and culture Mice were intravenously (i.v.) inoculated with 5 lg of aGC 7-9 days in advance. In some cases, spleen DCs and B cells pulsed with graded doses of aGC, as indicated, for 1 h at 37°C were injected i.v. into the mice in the quantities indicated.
iNKT cells were enriched as cells binding aGC/CD1d-Ig by MACS sorting using PE-conjugated anti-mouse IgG 1 and anti-PE mAb-coupled magnetic beads (purity >85%) from spleen or liver cells depleted of cells bearing CD8a, CD11b, CD16/CD32, CD45R, CD62L and MHC class II using sheep anti-rat IgG Dynabeads (Dynal, Oslo, Norway). For in vitro re-stimulation experiments, iNKT cells were further purified as PE-aGC/CD1d-Ig + FITC-CD19 -cells by FACSVantage (purity >98%).
CD11c + spleen-and bone marrow (BM)-derived DCs were prepared as described previously (21, 22) . CD19
+ spleen B cells were obtained by MACS sorting.
Purified iNKT cells prepared from normal and pre-treated mice with 5 lg of aGC were cultured at 0.5-1 3 10 4 cells per well in round-bottomed 96-well culture plates with 1 3 10 4 of splenic CD11c
+ cells in the presence or absence of 100 ng ml À1 of aGC in RPMI1640 medium supplemented with 5% FCS, 50 lM 2-mercaptoethanol, 100 U/ml penicillin and 100 lg ml À1 streptomycin (R5) for 3 days. In some experiments, 10 lg ml À1 of blocking mAbs or 100 ng ml À1 of recombinant mouse IL-2 (rIL-2) or IL-15 were added to culture.
In order to induce anergy in vitro, iNKT cells seeded at 2 3 10 5 cells per well in 96-well round-bottomed plates were stimulated with graded doses of immobilized anti-CD3 mAb in the presence or absence of graded doses of anti-CD28 mAb (0-10 lg ml
À1
) for 16 h. After washing with R5 three times, the cells were re-plated in new vessels and allowed to rest for 2 days. In some experiments, iNKT cells and OT-II CD4 T cells were treated with 1000 ng ml À1 of ionomycin (Sigma-Aldrich, St Louis, MO, USA) with or without 50 ng ml
of PMA (Sigma-Aldrich) for 16 h. After collecting, viable cells at 5 3 10 3 cells were re-stimulated with 10 4 splenic DCs in the presence or absence of 100 ng ml À1 aGC or 1 lg ml
of OT-II-specific ovalbumin peptide (OVA) for 3 days. At the end of culture, supernatants were collected and cytokine production was determined by sandwich ELISA. In some experiments, cytokine production in sera was determined at various time points after the injection of aGC-loaded cells using cytometric bead array (Mouse Inflammation Kit and Mouse T h 1/T h 2 Kit; BD Biosciences).
Quantitative reverse transcription-PCR
Total RNA was extracted using TRIzol (Invitrogen Life Technologies). Real-time PCR was performed with QuantiTect SYBR Green PCR kit (QIAGEN GmbH, Hilden, Germany) for IL-4, IFN-c and hypoxanthine guanine phosphoribosyl transferase 1 (HPRT) as internal control. Reverse transcription and PCR amplification were performed according to the manufacturer's instructions. Cycling was performed at 50°C for 30 min, 95°C for 15 min, 60 cycles at 94°C for 15 s, at 60°C for 30 s and at 72°C for 30 s. The amount of amplicon generated during the PCR was monitored using a Rotor-Gene 2000 (Corbett Research, Mortlake, Australia) apparatus. Analysis was performed on a Rotor-Gene version 5.0 (Corbett Research). Primer sequences were as follows: IL-4, sense 5#-CTTCCAAGGTGCTTCGCATATTTTA-3# and anti-sense 5#-CATGATGCTCTTTAGGCTTTCCAG-3#; IFN-c, sense 5#-GCCTAGCTCTGAGACAATGAACGC-3# and anti-sense 5#-AGATATCCAAGAAGAGACTCTTTTC-3#;
HPRT, sense 5#-CTTCAGGGATTTGAATCACGTTTG-3# and anti-sense 5#-TAATTTTACTGGCAACATCAACAG-3#.
Statistical analysis
Data are expressed as the mean 6 SD of triplicate cultures. Statistical significances were determined by the Student's t-test. Differences were considered to be significant for P-values <0.05. All experiments were performed at least three times and representative results are shown.
Results
Function and phenotype of anergized iNKT cells by soluble aGC
It has been reported that the injection of a high dose of aGC induces unresponsiveness of iNKT cells to any subsequent stimulation (13) (14) (15) (16) (17) . Thus, we first confirmed the anergy of the iNKT cells that had been stimulated with 5 lg of aGC 9 days in advance. iNKT cells obtained from the spleen and liver were re-stimulated by aGC in the presence of spleen DCs in vitro, and cytokine production was then measured. Not only spleen but also liver iNKT cells produced remarkably low amounts of IFN-c and IL-4 ( Fig. 1A) .
In conventional T cells, it is widely accepted that IL-2 can reverse the anergic state (23) . IL-2 shares its IL-2/IL-15Rb chain (CD122) and common c chain with IL-15. Moreover, IL-15 is known to be important for both iNKT cell development and homeostasis (24, 25) . Thus, we examined the receptor expression for these cytokines. Compared with iNKT cells from normal mice, iNKT cells pre-exposed to aGC reduced IL-2Ra but did not reduce either IL-15Ra or IL-2/IL-15Rb (Fig. 1B) . In addition, anergized iNKT cells slightly up-regulated IL-2Ra expression upon the re-stimulation with anti-CD3 and anti-CD28 (Fig. 1C) . Furthermore, exogenous IL-2 was incapable of restoring IFN-c production by anergized iNKT cells, although it effectively restored proliferation and IL-4 production (Fig. 1D) , as reported previously (14) . Unlike IL-2, exogenous IL-15 had marginal effect on the proliferation and IL-4 production. iNKT cells as well as NK cells expressed cytokine mRNAs, such as IFN-c and IL-4, in the steady state (26) . Thus, we used quantitative PCR to measure the mRNA levels of the respective cytokines. The results demonstrated that anergized iNKT cells contained decreased amounts of IFN-c mRNA, but increased amounts of IL-4 mRNA compared with unstimulated iNKT cells (Fig. 1E) , which is consistent with the different roles of IL-2 on IFN-c and IL-4 production and suggests that pre-activation of iNKT cells skews the cytokine production potential.
Role of PD-1 in the induction and maintenance of iNKT cell anergy
Other investigators have recently reported that anergic iNKT cells up-regulated inhibitory molecules such as PD-1 and BTLA and that PD-1 is responsible for the induction of the iNKT cell anergy at the time of activation (15, 17) . Therefore, we also monitored the expression of PD-1 and BTLA in comparison with TCR and CD28 expression and confirmed a remarkable up-regulation of PD-1 at 9 days after aGC injection ( Fig. 2A) . The effect of blocking mAb to PD-1 was then examined on anergized iNKT cell responsiveness to produce cytokines upon the re-stimulation in vitro. As with the results of Parekh et al. (17) , but not of Chang et al. (15) , blocking mAb to PD-1 had almost no impact on the reversal of the hyporesponsiveness of anergized iNKT cells (Fig. 2B) .
To further examine the involvement of PD-1 in the induction of iNKT cell anergy, we measured the serum cytokine activity of PD-1 KO mice. The injection of aGC was as effective in the induction of iNKT cell anergy to any subsequent stimulation in PD-1 KO mice as in wild-type (WT) mice (Fig. 2C) and such an anergy lasted at least a month in PD-1 KO mice as well as WT mice (data not shown). When these anergized iNKT cells were re-stimulated in vitro, they produced only a minimal amounts of cytokines, especially IFN-c (Fig. 2D) . These results indicate that PD-1 is not a primary contributor in the induction and maintenance of iNKT cell anergy. Spleen iNKT cells in PD-1-deficient mice that had been treated as in Fig. 1 were re-stimulated in vitro with spleen DCs and aGC for 3 days, and cytokine production was then assessed by ELISA. All data are representative of three or four independent experiments.
Induction of iNKT cell anergy in vitro
Activation of iNKT cells by aGC is dependent on the recognition of the aGC/CD1d complex via invariant TCR. In order to mimic the activation of iNKT cells to become anergic, purified iNKT cells were stimulated with graded doses of immobilized anti-CD3 mAb, followed by resting for 2 days and then restimulated with aGC in the presence of spleen DCs. After the primary stimulation, iNKT cells produced IFN-c, IL-4 and IL-2 in a dose-dependent manner (Fig. 3A, left panels) . However, cytokine production by pre-activated iNKT cells decreased as Fig. 3 . Induction of spleen iNKT cell unresponsiveness in vitro. (A) Spleen iNKT (2 3 10 5 cells per well) cells were stimulated with graded doses of immobilized anti-CD3 mAb in 96-well round-bottomed culture plates for 16 h and allowed to rest for 2 days after the wash, followed by restimulation at 5 3 10 3 cells per well with 10 4 spleen DCs in the presence or absence of 100 ng ml À1 of aGC for 3 days. Cytokines in the culture supernatants at 16 h of the first culture (three left panels) and 3 days of the re-stimulation culture (three right panels) were assessed. As in (A), spleen iNKT cells (B) and OT-II T cells (C) were stimulated with immobilized anti-CD3 mAb at 10 lg ml À1 in the presence of graded doses of anti-CD28 mAb for 16 h. After 2 days rest, recovered iNKT and OT-II T cells were cultured with spleen DCs in the presence or the absence of 100 ng ml À1 aGC or 1 lg ml À1 of OT-II-specific OVA peptide for 3 days, and cytokines in the culture supernatants were then measured.
the dose of anti-CD3 mAb in the primary stimulation was increased (Fig. 3A, right panels) , showing the inverse correlation between the magnitude of the primary response and the responsiveness to the secondary stimulation. Co-stimulation is well known to be required for priming conventional T cells in response to the specific antigen through the recognition by TCR (27, 28) . Therefore, the effect of CD28-mediated co-stimulation together with CD3-mediated TCR signaling was examined on the primary and secondary cytokine production in comparison with the production in CD4
+ OT-II T cells. Cytokine production by anti-CD3 was enhanced along with the increase in the dose of anti-CD28 mAb in both iNKT cells (Fig. 3B, left panels) and OT-II T cells (Fig. 3C, left panel) . However, pre-activated iNKT cells inversely reduced the response upon the restimulation with aGC in the presence of spleen DCs (Fig. 3B, right panels) . Moreover, these pre-activated iNKT cells by anti-CD3 + CD28 were incapable of producing IFN-c even in the presence of IL-2, as in those anergized in vivo (data not shown). In contrast, pre-activated OT-II T cells with a high dose of anti-CD28 produced comparable amounts of IFN-c to non-activated cells but those without anti-CD28 were refractory to the re-stimulation with specific OVA and spleen DCs (Fig. 3C, right panel) . Similar tendencies were also observed using liver iNKT cells (data not shown).
Moreover, both iNKT cells and OT-II T cells produce IFN-c in response to ionomycin + PMA but not ionomycin alone (Fig. 4A) . To the subsequent stimulation with spleen DCs in the presence of appropriate respective antigen, only iNKT cells showed anergic state after the stimulation with ionomycin + PMA, whereas OT-II cells pre-treated with ionomycin alone became anergic (Fig. 4B) , as previously reported (29) . These results together clearly demonstrate the different mechanism of anergy induction between iNKT cells and conventional CD4
+ T cells and suggest that the co-stimulation facilitates the induction of iNKT cell anergy.
aGC-loaded DCs induced iNKT cell anergy in vivo
DCs are well documented to be a primary APC for iNKT cell activation in vivo as well as in vitro. The inefficiency of B cells as APCs was supposed to be due to the lack of co-stimulatory molecules (30) . However, aGC-loaded B cells were able to induce IL-4 production, but little IFN-c production, from iNKT cells only when injected in vivo (5, 31). The results shown in Fig. 3 indicating the efficient induction of iNKT cell anergy along with co-stimulation raise the possibility that DCs are potent APCs in the activation of iNKT cells but also in the induction of the subsequent anergy.
To address this possibility, DCs were pulsed with graded doses of aGC and injected into normal mice, and the responsiveness of spleen iNKT cells was analyzed in vitro 9 days later. The iNKT cell anergy was evidently induced by DCs in an aGC dose-dependent manner (Fig. 5A) . Next, we compared DCs with B cells in terms of their iNKT cell-activating and anergy-inducing ability. Although DCs were much more potent in terms of activating iNKT cells to produce cytokines, B cells also induced significant amounts of cytokines in a dose-dependent manner (Fig. 5B) . It was also shown that DCs were much more potent in inducing iNKT cell anergy than B cells (Fig. 5C) . Similar results were obtained in liver iNKT cells (data not shown). These results confirmed that iNKT cells lapsed into anergy in vivo even when they received signals through both TCR and co-stimulatory molecules on professional APCs.
Discussion
A single injection of a high dose of aGC induced longlasting iNKT cell anergy following the robust production of cytokines, such as IFN-c and IL-4 (13) (14) (15) (16) (17) . In contrast, conventional CD4 T cells are shown to become anergic without producing cytokines when stimulated via TCR in the absence of co-stimulation (32) . Therefore, in this study we monitored the consequences of activated iNKT cells and the requirement for co-stimulation in order to induce iNKT cell anergy compared with conventional CD4 T cells. Fig. 4 . Requirement of complete stimulation to induce iNKT cell unresponsiveness. Spleen NKT cells and OT-II T cells were stimulated with 1 lg ml À1 of ionomycin with or without 50 ng ml À1 PMA for 16 h (A) and then re-stimulated with spleen DCs in the presence or absence of aGC or OVA peptide for 3 days (B). Cytokine production was determined as in Fig. 3 . All data are representative of two or three independent experiments.
As in conventional T cells, exogenous IL-2, but not IL-15, restored the proliferation of anergic iNKT cells (Fig. 1D) , as has been reported by Parekh et al. (14) . Our results additionally showed that IL-2 rescued anergic iNKT cells so that they produced more IL-4 than normal iNKT cells. However, IFN-c production by anergic iNKT cells was not restored. This polarized cytokine production by anergized iNKT cells seems to be related to respective mRNA levels, in which there were increased and decreased amounts of IL-4 and IFN-c mRNAs, respectively. Recently, Kojo et al. clearly demonstrated that the anergized iNKT cells increase the expression level of an E3 ubiquitin ligase, casitas B-lineage lymphoma-b (Cbl-b), and that Cbl-b deficiency largely rescues the decreased IFN-c production by aGC-pre-treated iNKT cells (16) . They also showed that the decreased proliferative activity and IL-4-producing activity of aGC-pre-treated iNKT cells were not restored by Cbl-b deficiency. Since it has been reported that IL-4 production is reliant on the Ca 2+ -dependent nuclear factor of activated T cells (NFAT)2-mediated signaling pathway (33) and that Erg2 (early growth response 2), a target of NFAT, supports iNKT cell survival (34) ; the regulatory mechanisms of hyporesponsiveness of anergized iNKT cells to produce cytokines may be distinct.
It has been well documented that PD-1 expression induced by antigenic stimulation plays an important role in halting the excessive responses concomitant with the upregulation of PD-1 ligands, such as PD-L1 and PD-L2, on various cell types, including DCs (35) . Recently, two groups have reported that PD-1 also regulates iNKT cell anergy induction and maintenance (15, 17) . However, the involvement of PD-1 in the maintenance of the anergic state of preactivated iNKT cells is controversial in these studies. Our result showing that anti-PD-1 mAb has only a minimal effect on the cytokine production by anergized iNKT cells is consistent with that by Parekh et al. (17) , but we were unable to confirm the contribution of PD-1 in iNKT cell anergy induction in situ. In addition, stimulation with immobilized anti-CD3 mAb and anti-CD28 mAb induced PD-1 KO iNKT cell anergy comparable to that of WT iNKT cells in vitro (data not shown), demonstrating that PD-1 is not involved in iNKT cell anergy induction. It is not clear why the results are inconsistent. In previous studies, mice were treated intra-peritoneally with 2 lg of aGC a month before the start of the experiment, instead of i.v. injection with 5 lg of aGC 9 days beforehand as in our experiments. Therefore, the anergic state induced by a weaker stimulation may not last long, and responsiveness may be rescued by blocking PD-1/PD-L interaction, leading to the apparent recovery from anergy.
Like PD-1, BTLA is a co-inhibitory molecule belonging to the Ig superfamily (36) . BTLA deficiency counteracts the induction of oral tolerance mediated by T cells (37) and also enhances the iNKT cell response to produce cytokines (38) . Experiments still need to be carried out to elucidate the involvement of BTLA in the induction and maintenance of iNKT cell anergy. However, we suspect that BTLA is involved since strong stimulation via TCR with co-stimulation is required for the induction of iNKT cell anergy, which is shown in the present study. It may be possible that BTLA interferes with CD28-mediated signaling in the activation of iNKT cells as PD-1 (36). + DCs were pulsed with or without graded doses of aGC for 1 h at 37°C. After washing, 2.5 3 10 6 cells were injected i.v., and iNKT cell responsiveness was determined by re-stimulation, as in Fig. 1 
. (B) Spleen CD11c
+ DCs and CD19 + B cells were pulsed with or without 2.5 lg ml À1 of aGC for 1 h at 37°C. After washing, graded numbers of them were injected i.v. and the cytokines produced in the sera were determined at various time points using cytometric bead array. Each dot represents the mean cytokine activity of three mice. (C) Nine days after the injection of aGC-pulsed DCs and B cells as in (B), the responsiveness of spleen iNKT cells was measured as in (A). A representative result of three independent experiments is shown.
Unlike naive T cells, iNKT cells express cytokine mRNAs when in the steady state and secrete them immediately after the antigenic stimulation, followed by the anergy to the further activating stimuli (26) . Our in vitro culture system to induce iNKT cell anergy clearly demonstrated that, in contrast to naive T cells, iNKT cells required a strong activation signal together with TCR and co-stimulation. There appeared to be a correlation between anergy induction of iNKT cells in vitro and the production of cytokines in vivo. In addition, although naive T cells stimulated by ionomycin alone, which induces Ca 2+ influx, became anergic without IFN-c production, iNKT cells did not become anergic without concomitant stimulation with PMA. These results strengthen the possibility of the requirement for co-stimulation.
Parekh et al. have reported that aGC-loaded DCs did not induce NKT cell anergy, whereas aGC-loaded B cells were potent inducers of iNKT cell anergy (14) . Our results also demonstrated that aGC-loaded B cells induced iNKT cell anergy after a single injection. However, aGC-loaded spleen DCs were much more potent than B cells. In addition, similar results were obtained when LPS-activated BM DCs were used (data not shown). The discrepancy with the results by Parekh et al. is not clear. We thus conducted experiments using exactly the same protocol, but the results showed again that aGC-loaded spleen DCs were able to induce iNKT cell anergy. Using MZB cells that expressed the highest level of CD1d (4), Bialecki et al. have recently reported that a single injection of aGC-loaded cells induced cytokine production by iNKT cells in vivo, although they were unable to activate iNKT cells in vitro (31) . Therefore, aGC could be released from B cells and presented by endogenous DCs in vivo (39) . This is evidently feasible since IL-12p70 production was induced, possibly from DCs, when a large number of aGC-loaded B cells was injected. Intriguingly, it has been shown that iNKT cells become anergic after the rapid activation and proliferation by BCG infection, although specific T-cell priming is not affected (40) . When microbes are injected in vivo, phagocytic APCs, such as DCs, present protein antigens to T cells and lipid antigens to iNKT cells. Microbes containing various kinds of pathogen-associated molecular patterns activate DCs, leading to up-regulation of presentation of microbial-derived lipid antigens and selfantigen, such as iGb3 (isoglobotrihexosylceramide), to iNKT cells (41) . These results are consistent with our results presented in this study and support our hypothesis regarding the role of DCs in the induction of iNKT cell anergy.
All in all, the present study clearly demonstrates that, in contrast to conventional T cells, DCs are the most potent APCs not only for activating iNKT cells but also for subsequently inducing their unresponsiveness to the following antigenic stimulation, particularly the production of IFN-c. Further studies will be needed to clarify the exact regulatory mechanism for IFN-c and IL-4 production in anergized iNKT cells and the anergy-inducing mechanism by strong TCR signals together with co-stimulation. 
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